These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17602158)

  • 1. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis.
    Sepandj F; Ceri H; Gibb A; Read R; Olson M
    Perit Dial Int; 2007; 27(4):464-5. PubMed ID: 17602158
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
    Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
    Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():483-5. PubMed ID: 9331699
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiology of peritonitis.
    Ahmetagic A; Numanovic F; Ahmetagic S; Rakovac-Tupkovic L; Porobic-Jahic H
    Med Arch; 2013; 67(4):278-81. PubMed ID: 24520754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low recovery rates of high-level aminoglycoside-resistant enterococci could be attributable to restricted usage of aminoglycosides in Indian settings.
    Sekar R; Srivani R; Vignesh R; Kownhar H; Shankar EM
    J Med Microbiol; 2008 Mar; 57(Pt 3):397-398. PubMed ID: 18287308
    [No Abstract]   [Full Text] [Related]  

  • 6. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
    Mohan B; Garg S; Appannanavar SB; Taneja N
    Indian J Med Microbiol; 2016; 34(3):398-9. PubMed ID: 27514977
    [No Abstract]   [Full Text] [Related]  

  • 7. Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.
    Halle E; Padberg J; Rosseau S; Klare I; Werner G; Witte W
    Infection; 2004 Jun; 32(3):182-3. PubMed ID: 15188081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Tedizolid against Enterococci and Staphylococci, Including
    Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
    Furlong WB; Rakowski TA
    Clin Infect Dis; 1997 Jul; 25(1):163-4. PubMed ID: 9243059
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants.
    Jahansepas A; Aghazadeh M; Rezaee MA; Hasani A; Sharifi Y; Aghazadeh T; Mardaneh J
    Microb Drug Resist; 2018; 24(1):76-82. PubMed ID: 28525287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo daptomycin-nonsusceptible enterococcal infections.
    Kelesidis T; Humphries R; Uslan DZ; Pegues D
    Emerg Infect Dis; 2012 Apr; 18(4):674-6. PubMed ID: 22469288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing future treatment of enterococcal infections: attacking the biofilm?
    Paganelli FL; Willems RJ; Leavis HL
    Trends Microbiol; 2012 Jan; 20(1):40-9. PubMed ID: 22169461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy.
    Yuste JR; Quesada M; Díaz-Rada P; Del Pozo JL
    Int J Infect Dis; 2014 Oct; 27():65-6. PubMed ID: 25192907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Level of Resistance in Enterococci Isolated in Four Hospitals, Marseille, France.
    Abat C; Raoult D; Rolain JM
    Microb Drug Resist; 2016 Apr; 22(3):218-22. PubMed ID: 26247097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA; Sobottka I; Feucht HH; Claussen M; Kaulfers PM; Laufs R; Mack D
    Chemotherapy; 2000; 46(2):104-10. PubMed ID: 10671760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
    Johnson AP; Warner M; Woodford N; Speller DC; Livermore DM
    BMJ; 1998 Sep; 317(7159):629-30. PubMed ID: 9727989
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Action and Biofilm Inhibitory Activity of Lupinifolin Against Multidrug-Resistant Enterococcal Clinical Isolates.
    Sianglum W; Muangngam K; Joycharat N; Voravuthikunchai SP
    Microb Drug Resist; 2019 Dec; 25(10):1391-1400. PubMed ID: 31314663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.